FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

840711000168100: Boostrix-IPV (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection, 0.5 mL syringe (trade product unit of use)

Status: current, Defined. Date: 31-Oct 2016. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3109781000168110 Boostrix-IPV (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection, 0.5 mL syringe (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3109791000168113 Boostrix-IPV injection, 0.5 mL syringe en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Boostrix-IPV injection, 0.5 mL syringe has manufactured dose form injection true Inferred relationship Some
Boostrix-IPV injection, 0.5 mL syringe Is a trade product unit of use true Inferred relationship Some
Boostrix-IPV injection, 0.5 mL syringe Is a Boostrix-IPV true Inferred relationship Some
Boostrix-IPV injection, 0.5 mL syringe Is a diphtheria + tetanus + pertussis 3 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL syringe true Inferred relationship Some
Boostrix-IPV injection, 0.5 mL syringe has manufactured dose form injection suspension false Inferred relationship Some
Boostrix-IPV injection, 0.5 mL syringe has unit of use syringe true Inferred relationship Some 2077530495
Boostrix-IPV injection, 0.5 mL syringe has Australian BoSS Bordetella pertussis pertactin antigen true Inferred relationship Some 1403065152
Boostrix-IPV injection, 0.5 mL syringe has intended active ingredient Bordetella pertussis pertactin antigen true Inferred relationship Some 1403065152
Boostrix-IPV injection, 0.5 mL syringe has intended active ingredient tetanus toxoid true Inferred relationship Some 260614494
Boostrix-IPV injection, 0.5 mL syringe has Australian BoSS tetanus toxoid true Inferred relationship Some 260614494
Boostrix-IPV injection, 0.5 mL syringe has Australian BoSS Bordetella pertussis filamentous haemagglutinin antigen true Inferred relationship Some 1086153174
Boostrix-IPV injection, 0.5 mL syringe has intended active ingredient Bordetella pertussis filamentous haemagglutinin antigen true Inferred relationship Some 1086153174
Boostrix-IPV injection, 0.5 mL syringe has Australian BoSS poliovirus type 2 inactivated antigen true Inferred relationship Some 584207098
Boostrix-IPV injection, 0.5 mL syringe has intended active ingredient poliovirus type 2 inactivated antigen true Inferred relationship Some 584207098
Boostrix-IPV injection, 0.5 mL syringe has intended active ingredient poliovirus type 1 inactivated antigen true Inferred relationship Some 2077530494
Boostrix-IPV injection, 0.5 mL syringe has Australian BoSS poliovirus type 1 inactivated antigen true Inferred relationship Some 2077530494
Boostrix-IPV injection, 0.5 mL syringe has Australian BoSS diphtheria toxoid true Inferred relationship Some 1030499618
Boostrix-IPV injection, 0.5 mL syringe has intended active ingredient diphtheria toxoid true Inferred relationship Some 1030499618
Boostrix-IPV injection, 0.5 mL syringe has Australian BoSS Bordetella pertussis toxoid true Inferred relationship Some 1676693936
Boostrix-IPV injection, 0.5 mL syringe has intended active ingredient Bordetella pertussis toxoid true Inferred relationship Some 1676693936
Boostrix-IPV injection, 0.5 mL syringe has Australian BoSS poliovirus type 3 inactivated antigen true Inferred relationship Some 1002228594
Boostrix-IPV injection, 0.5 mL syringe has intended active ingredient poliovirus type 3 inactivated antigen true Inferred relationship Some 1002228594
Inbound Relationships Type Active Source Characteristic Refinability Group
Boostrix-IPV injection, 0.5 mL syringe has TPUU True Boostrix-IPV injection, 0.5 mL syringe Inferred relationship Some 1
Boostrix-IPV injection, 10 x 0.5 mL syringes has TPUU True Boostrix-IPV injection, 0.5 mL syringe Inferred relationship Some 1
Boostrix-IPV injection, 10 x 0.5 mL syringes has TPUU True Boostrix-IPV injection, 0.5 mL syringe Inferred relationship Some 1
Boostrix-IPV (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection, 1 x 0.5 mL syringe (trade product pack) has TPUU True Boostrix-IPV injection, 0.5 mL syringe Inferred relationship Some 1

Reference Sets

Vaccine reference set

Trade product unit of use reference set

Back to Start